Track the Bluejay Diagnostics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Bluejay Diagnostics, Inc. has published 23 public disclosures. Market capitalisation: €1.1m. The latest transaction was disclosed on 18 August 2026 (Attribution). Among the most active insiders: Dey Indranil. The full history is openly available.
23
Insider Decl.
n/a
Thresholds
€258,883
12 ops.
Buy Volume
€42,726
1 ops.
Sell Volume
42Σ signal
Buys €258,883€42,726 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,500 shares@ US$0.9577.6% of flowCommon StockSEC:0001213900-22-013084:0
Canonical exit: 12 Jun 2022 (T+90)
23 of 23 declarations
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. is a company focused on developing medical diagnostic solutions. It aims to enhance healthcare through innovative technologies.